1 terminated. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Terminated 1 |
Follow RXDX-106: new trials by email Literature Review of RXDX-106 trials Research Report on RXDX-106
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oral Immunomodulatory Tyrosine Kinase Inhibitor in Patients With Locally Advanced or Metastatic Solid Tumors RXDX-106 - Advanced or Metastatic Solid Tumors | Early Phase 1 | Terminated | Hoffmann-La Roche | 1 | 2018-02-15 | 2019-04-25 |
Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Squamous Cell (1) · Carcinoma, Transitional Cell (1) · Hodgkin Disease (1) · Melanoma (1)
United States (1)
Pratik S. Multani, MD, MS (1) · Sandra Pierina D'Angelo, MD (1)